BRAF and neoplasm: No other significant associations were found for either MSS or MSI-H cases between ITF2 methylation and early age of onset (<50 years), stage, grade, tumor location, histological type, MMR protein status, MMR germline mutation, BRAF V600E mutation, or survival status.